Cingulate Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Cingulate Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cingulate Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cingulate Inc. is CING:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cingulate Inc. has its primary listing on NASDAQ (Small cap). You can trade Cingulate Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cingulate Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cingulate Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cingulate Inc..